SCHEMBL28614014

SCHEMBL28614014

C[CH]Oc1cc([N+](=O)[O-])ccc1OCOC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
MAPT P10636 9/20 0.45
TDP1 Q9NUW8 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
HPGD P15428 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
LMNA P02545 5/20 0.41
ALDH1A1 P00352 4/20 0.41
CYP19A1 P11511 1/20 0.40
PTGS2 P35354 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5407163 0.85 HTT (0.58) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL30235266 0.82 HTT (0.58) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL18087973 0.82 HTT (0.58) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL27593208 0.81 HTT (0.46) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL6210671 0.80 HTT (0.53) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL755913 0.79 HTT (0.68) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL30729438 0.79 HTT (0.68) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL20786648 0.79 MAPT (0.45) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL14101860 0.78 ERN1 (0.50) HTTMAPTTDP1SMN1; SMN2HPGD
SCHEMBL2766450 0.78 MAPT (0.63) MAPTTDP1SMN1; SMN2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109422737-B Imidazolone androgen receptor antagonist, preparation method and application thereof 上海时莱生物技术有限公司 2021-07-30 CN disclosed